Welcome to Talking Justice Sign in | Join | Help
in
Justice Talking About All Blogs Today's Blog Forums

American Tort Reform Association

Since 1986, American Tort Reform Association is the only national organization exclusively dedicated to reforming the civil justice system. ATRA was co-founded in 1986 by the American Medical Association and the American Council of Engineering Companies. Since that time, ATRA has been working to bring greater fairness, predictability and efficiency to America's civil justice system. ATRA is a nonpartisan, nonprofit organization with affiliated coalitions in more than 40 states. ATRA's membership is diverse and includes nonprofits, small and large companies, as well as state and national trade, business, and professional associations.

About Sherman Joyce

SHERMAN JOYCE is President of the American Tort Reform Association (ATRA), a national coalition of more than 300 non-profit organizations, professional societies, trade associations and corporations working through in-state coalitions to bring fairness and efficiency to the civil justice system. As President of ATRA, Mr. Joyce is the Association's Chief Executive Officer and a member of its Board of Directors.

Upon graduation from Princeton University, Joyce served as a legislative assistant to U.S. Senator John C. Danforth (R - MO) until 1984. Following graduation from Catholic University Law School, he served as minority counsel to the Subcommittee on Science, Technology and Space of the Senate's Committee on Commerce, Science and Transportation from 1987 to 1989.

He then moved to the minority counsel position with the committee's Subcommittee on the Consumer where he led Republican efforts to establish uniform rules for product liability law. In addition, he advised Senators on issues pertaining to product safety, antitrust law, advertising, and consumer and telemarketing fraud.

Accepting leadership responsibilities with ATRA in 1994, Joyce has since appeared on numerous television and radio programs to discuss civil justice issues, and he has been quoted extensively in newspapers across the country. In 1995 the National Law Journal recognized him as one of its "40 under 40", a compilation of 40 influential lawyers in the nation under age 40.


WARNING: Tort Lawyers' Solicitations May Be Hazardous to Your Health

It’s bad enough when plaintiffs’ lawyers unlawfully pay clients to serve as props in speculative shareholder litigation, bribe judges or conspire to present fraudulent medical evidence in thousands of lawsuits that crowd court dockets and delay justice for those with legitimate health claims.

But now there’s evidence that personal injury lawyers’ brazenly deceptive online trolling for new clients is actually putting the health of Americans at risk. Lives are at stake, and Congress and state bar associations should act.

A recently published report from the New York-based Center for Medicine in the Public Interest (http://drugwonks.com/CMPI_Insta_American_Study_01_08_08.pdf) demonstrates that many Americans are routinely misled when conducting Internet searches about illnesses or medical conditions from which they or loved ones suffer.

CMPI says its analysis revealed that Internet search results are “dominated by Web sites paid for and sponsored by either class action law firms or legal marketing sites searching for plaintiff referrals.”

Robert Goldberg, CMPI vice president and coauthor of the report, said, “What we found was not only disturbing, but dangerous to public health.” Millions of Americans now resort to Google searches more readily than consultations with the family physician, he explained. “People trust, and make decisions, based on information they find online.” 

But with few exceptions, Goldberg added, the information that he and colleagues found online “had no medical authority whatsoever.  In many cases, we found lawyers posing as medical experts.”

In fact, the tort lawyers’ masquerading Web sites are shamelessly designed to gin up clients for speculative litigation. Rather than getting unbiased, scientifically sound information, visitors to these sites unknowingly get skewed, misleading information that hypes risks, ignores benefits and can actually frighten them away from life-saving drugs or treatments.

Typically such Web sites eventually lead visitors to a page that ominously suggests, “If you’ve taken Drug X, you may be at considerable risk for Side Effect Y, and you may have grounds for a lawsuit.”

Among four telling case studies, the CMPI report cites an article based on “questionable methodologies” and a biased editorial that were published together in the New England Journal of Medicine in May 2007, making unfounded allegations that use of the FDA-approved and widely prescribed diabetes drug Avandia could lead to cardiovascular disease.  According to the report, media stories and Internet postings quickly proliferated, as did trial lawyer efforts to drive litigation against the drug’s maker.

“Despite all of the scientific evidence that demonstrates Avandia effectively treats diabetes, patients may choose not to take the medication based on the information they find online, even though the benefits of the medication far outweigh the risks,” the CMPI report warns.

A recent Merrill Lynch analysis also concluded that “Some patients appear to have simply been scared off . . . Avandia” and “alternative oral medications.” Of course, diabetes comprises a growing epidemic in America and, if untreated, can lead to blindness, even loss of limbs.  

Blithely ironic or just ruthlessly efficient, personal injury lawyers have also targeted the beneficial anti-psychotic Zyprexa for allegedly increasing the risk of ― you guessed it ― diabetes.  

CMPI’s report doesn’t cover Zyprexa but, in a survey reported by the Associated Press in June 2007, more than half of 402 randomly surveyed psychiatrists who treat patients with bipolar disorder or schizophrenia indicated that some of those patients stopped taking the drug or reduced their dosage upon seeing lawyers’ advertisements.  So, in its drive to file ever more groundless lawsuits, the tort bar has put the mental health of a particularly vulnerable universe of patients at considerable risk.

And in what may constitute the most egregious example of trial lawyer selfishness, the very lives of another vulnerable universe of patients, young people taking antidepressants, have also been jeopardized.

The CMPI report details how baseless allegations linking certain antidepressants to increased risks of suicide in young people appear to have taken a heartbreaking toll. Negative coverage online and in traditional media resulted in “a sharp decrease in antidepressant prescriptions” as families resisted such prescriptions for their youngsters and, fearing litigation, doctors stopped writing them.

“At the same time,” the report observes, “there was an increase in depression and suicide.”  

But rather than acknowledge a problem and lead her membership in a voluntary embrace of transparency and accountability, Kathleen Flynn Peterson, president of the tort bar’s American Association for Justice, has instead attacked CMPI’s report, calling it "laughable at best" and saying its "dubious methodology consists of nothing but Google searches."

Since the report is primarily about Google searches, Peterson is willfully avoiding its point, leaving to state bar associations the responsibility for ending lawyers’ inherently misleading client recruitment.  Minimally, all lawyers should be required to identify themselves clearly and conspicuously on Web sites they sponsor.  And since there’s nothing “laughable” about risks to public health, Congress should commence appropriate oversight, too.  

Published Sunday, January 20, 2008 11:59 PM by Sherman Joyce

© American Tort Reform Association. All rights reserved.

Anonymous comments are disabled. Click "Join" at top-right to add comments.

Closed to Comments

Note: Justice Talking ceased production on June 30 of 2008. The Talking Justice blogs and forums are provided as a read-only resource for historical interest only. Commenting on blog posts has been suspended.

All opinions expressed are those of the author. The Annenberg Public Policy Center makes no claim as the the accuracy of claims or continued availability of any third party web links found on this site.

This Blog

Select Blog by Day

Syndication